A previous study demonstrated that power against the (unobserved) true effect for the primary end point (PEP) of most phase III oncology trials is low, suggesting an increased risk of false-negative ...

Higher levels of BDNF in the blood were linked to both more severe depressive symptoms (HADS-D score) and more severe asthma ...

This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.

Objectives Glaucoma is an optic neuropathy caused by the gradual degeneration of retinal ganglion cells. This study aimed to investigate the knowledge, attitude and practice (KAP) towards glaucoma ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.